Halozyme Therapeutics, Inc. (0J2O.L) Dividend Yield, History & Forecast

Halozyme Therapeutics, Inc. (0J2O.L) is a Medical - Pharmaceuticals company in the Healthcare sector listed on the London Stock Exchange. The most recent ex-dividend date was March 15, 2022. market capitalization is approximately $7.56B.

Loading quote...

Frequently Asked Questions about Halozyme Therapeutics, Inc. (0J2O.L)

When does Halozyme Therapeutics, Inc. pay its next dividend?
The most recent ex-dividend date was March 15, 2022.
Is Halozyme Therapeutics, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Halozyme Therapeutics, Inc. in?
Halozyme Therapeutics, Inc. (0J2O.L) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry.